All these data strongly support the link between GML and gastric adenocarcinoma and the necessity of strict surveillance of the gastric mucosa after GML treatment, even in cases of apparent complete remission, especially if the precancerous lesions are present concomitantly with the lymphoma, but also in the absence of these lesions which may appear afterward. This evidence concerns the gene GML and gastric adenocarcinoma.